CHU de Québec - Université Laval - Hôtel-Dieu de Québec

Québec G1J 1Z4

0 studies enrolling now · 2 studies all time

What they study most

Metastatic Prostate Cancer, Prostatic Neoplasms, Castration-Resistant

Studies at this site

• Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer — Completed
• A Study of Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen — Completed